Arcoma AB

ARCOMA · Nasdaq Stockholm · Healthcare

7.48SEK +3.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −19.6%

Performance

1 month

−7.0%

1 year

−19.6%

3 years, per year

+0.4%

5 years, per year

−16.3%

Largest fall, 3 years

−73.6%

Below the peak now

−70.8%

Volatility, 1 year

53.4%

Return with dividends reinvested.

Key figures

P/E

25.1

P/B

1.4

Dividend yield

0.0%

Return on equity

+5.4%

Net margin

+3.2%

Market value

11 m USD

Quality, value and trend

Where Arcoma stands against every Nordic stock today. 100 is best.

Quality61

Profitability and a sound balance sheet over time. Better than 61% of Nordic stocks.

Value72

The price measured against earnings, assets and cash flow. Better than 72% of Nordic stocks.

Trend25

The price development over the past year. Better than 25% of Nordic stocks.

Combined51

Quality, value and trend together. Better than 51% of Nordic stocks.

About Arcoma

Arcoma AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 33 employees.

Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanced remote control, form pad, hand control, compression belt, detector holder, foot control, lateral armrest, patient handgrip, mattress, scatter correction software, battery charger, battery pack, and stitching screen. It manufactures x-ray equipment under the Canon and Konica Minolta brand name.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis